TCL Archive ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma. December 10, 2004
TCL Archive FDA Asks Advisory Group To Define Role Of Single-Arm Studies In Four Applications September 4, 2009